The School of Chinese Medicine (SCM) yesterday (9 December) hosted the “2012 Summit on Innovative Drug Discovery in Hong Kong”. The event provided a platform for renowned scholars and experts in the field from the Mainland and Hong Kong to discuss the strategies and way ahead for drug discovery in Hong Kong. Officiating at the opening ceremony were Dr. Ko Wing-man, Secretary for Food and Health; Mr. Anthony Wu, Chairman of the Hospital Authority; Professor Ding Jian, Member of the Chinese Academy of Engineering, and Director of the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences; Professor Yao Xinsheng, Member of the Chinese Academy of Engineering, and Director of the Institute of Traditional Chinese Medicine and Natural Products of Jinan University; Professor Chen Kaixian, Member of the Chinese Academy of Sciences, and President of Shanghai University of Traditional Chinese Medicine; Professor Zhang Boli, Member of the Chinese Academy of Engineering, President of the China Academy of Chinese Medical Sciences, and President of Tianjin University of Traditional Chinese Medicine; Professor Albert Chan, Member of the Chinese Academy of Sciences, and President and Vice-Chancellor of HKBU; and Professor Lu Aiping, Dean of the School of Chinese Medicine of HKBU. Speaking at the opening ceremony, Dr. Ko Wing-man said that there was a lot of room for the development of Chinese medicine in Hong Kong. The Government is actively preparing for the establishment of the Chinese Medicine Development Committee for the purpose of pooling ideas and insights to map out the blueprint for the future development of Chinese medicine. Addressing the audience, Mr. Anthony Wu said that with the participation of top experts in the field, the Summit would provide impetus to the development, modernisation and internationalisation of Chinese medicine. With drug discovery being a herculean task, Mr. Wu expressed the hope that the Summit would lead to the achievement of groundbreaking results. In his speech, Professor Albert Chan said that innovative research is a long-term social investment which should be jointly undertaken by the Government, universities and the industry. He said he hoped that the Government would render strong support to innovative research initiatives by formulating policies and allocating resources. The tertiary education sector can work closely with enterprises on innovative drug discovery. In the long run, these efforts would benefit the local and global community. At the Summit, well-known scholars and experts in the field, including among others five academicians of the Chinese Academy of Engineering/Chinese Academy of Sciences, enlightened the audience with their expertise and insights on innovative drug discovery. The discussions have been a useful exchange on the modernisation of Chinese medicines.
(From left) Professor Albert Chan, Professor Yao Xinsheng, Professor Zhang Boli, Dr. Ko Wing-man, Mr. Anthony Wu, Professor Chen Kaixian, Professor Ding Jian, and Professor Lu Aiping officiate at the opening ceremony